ERBB2 and breast cancer: Likewise, similar results were reported in a Ukrainian retrospective study, which included 182 patients with stage II–III HR-positive/HER2-negative BC undergoing NAC with polychemotherapy with fluorouracil, doxorubicin, and cyclophosphamide or doxorubicin/cyclophosphamide.